Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age
Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:
“In transfusion medicine, prevention is always better than reaction.
One of the most critical yet often under-emphasized practices is extended phenotyping – especially for Rh (C, c, E, e) and Kell antigens in females.
Why does this matter?
Because alloimmunization doesn’t just affect a single transfusion – it can impact future pregnancies and neonatal outcomes.
A young female patient exposed to mismatched Rh or Kell antigens today may develop clinically significant antibodies tomorrow.
These antibodies can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), posing serious risks to both mother and baby.
By proactively providing Rh and Kell matched blood for females of childbearing age, we are not just ensuring safe transfusion – we are protecting future lives.
This is not just good practice.
It is responsible transfusion medicine.
Let’s move from compatibility to foresight.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy